Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
RICHMOND, Calif., Feb. 22, 2017 -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced the company plans to participate in the Cowen and Company Health Care Conference in Boston.
Ekso Bionics’ management is scheduled to present Wednesday, March 8, 2017 at 8:00 a.m. EST. A live and archived webcast of the presentation will be available on the investors section of the company’s website at: www.eksobionics.com.
About Ekso Bionics®
Ekso Bionics is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical, industrial and defense applications. Founded in 2005, the company continues to build upon its unparalleled expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe, to providing research for the advancement of R&D projects intended to benefit U.S. defense capabilities. The company is headquartered in the Bay Area and is listed on the Nasdaq Capital Market under the symbol EKSO. For more information, visit: www.eksobionics.com.
Media Contact: Carrie Yamond/Rajni Dhanjani 212-867-1788 [email protected] Investor Contact: Debbie Kaster 415-937-5403 [email protected]
